Our Irritable Bowel Syndrome (IBS) test is a valuable tool in clinical practice, aiding in the identification and management of this common gastrointestinal disorder. It serves multiple purposes, including the identification of the overgrowth of large intestinal bacteria in the small intestine and the release of bacterial cytotoxins, which are key contributors to IBS symptoms. Additionally, the test evaluates breaches in the intestinal barrier caused by bacterial cytotoxins and their entry into circulation, providing insights into the underlying mechanisms of IBS pathogenesis. By identifying these factors, the test assists in setting guidelines for the treatment of irritable bowel and small intestinal bacterial overgrowth (SIBO), helping to reduce the risk of igniting the autoimmune process. Recommended for patients experiencing symptoms of irritable bowel, malabsorption (such as weight loss, anemia, or fatty stools), and associated conditions like fatigue, reflux, skin disorders, obesity, or food intolerances, this test offers a comprehensive evaluation of immune reactivity associated with IBS. By assessing immune reactivity to these proteins, the test provides valuable insights into the underlying causes of IBS, enabling personalized treatment strategies for improved patient outcomes and overall well-being.